Molecular Docking Technique for Selection of Some Naproxen Derivatives as Inhibitors of Cyclooxygenase 2 (COX-2)

被引：0

作者：

Beteringhe, Adrian ^{[1
]}

Symeonidis, Flavia Corina Mitroi ^{[1
]}

机构：

[1] Lumina, Informat Technol & Commun Dept, Bucharest, Romania

来源：

PROCEEDINGS OF THE 2015 7TH INTERNATIONAL CONFERENCE ON ELECTRONICS, COMPUTERS AND ARTIFICIAL INTELLIGENCE (ECAI) | 2015年

关键词：

molecular docking; naproxen derivatives; COX-2; Hex; 8.0; ANTIINFLAMMATORY AGENTS; FUTURE; DRUGS; DISCOVERY; MECHANISM;

D O I：

暂无

中图分类号：

TP18 [人工智能理论];

学科分类号：

081104 ; 0812 ; 0835 ; 1405 ;

摘要：

Molecular Docking Technique has found utility in selecting of naproxen derivatives as inhibitors of cyclooxygenase 2, knowing the fact that naproxen inhibit both forms of cyclooxygenase.

引用

页码：BB13 / BB16

页数：4

共 50 条

[31] Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
Hassanein, Hassanein H.
Georgey, Hanan H.
Fouad, Marwa A.
El Kerdawy, Ahmed M.
Said, Mona F.
FUTURE MEDICINAL CHEMISTRY, 2017, 9 (06) : 553 - 578
[32] Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer
Dash, Raju
Uddin, Mir Muhammad Nasir
Hosen, S. M. Zahid
Bin Rahim, Zahed
Dinar, Abu Mansur
Kabir, Mohammad Shah Hafez
Sultan, Ramiz Ahmed
Islam, Ashekul
Hossain, Md Kamrul
BIOINFORMATION, 2015, 11 (12) : 543 - 549
[33] Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer
G. Aparicio Gallego
S. Díaz Prado
P. Jiménez Fonseca
R. García Campelo
J. Cassinello Espinosa
L. M. Antón Aparicio
Clinical and Translational Oncology, 2007, 9 : 694 - 702
[34] Design and synthesis of new 2,4,5-triarylimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors
Zarghi, A.
Arfaei, S.
Ghodsi, R.
MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (08) : 1803 - 1810
[35] Design and synthesis of new 2,4,5-triarylimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors
A. Zarghi
S. Arfaei
R. Ghodsi
Medicinal Chemistry Research, 2012, 21 : 1803 - 1810
[36] Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk
Ashok, Varun
Dash, Chiranjeev
Rohan, Thomas E.
Sprafka, J. Michael
Terry, Paul D.
BREAST, 2011, 20 (01): : 66 - 70
[37] Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study
El-Sayed, Magda A. -A.
Abdel-Aziz, Naglaa I.
Abdel-Aziz, Alaa A. -M.
El-Azab, Adel S.
Asiri, Yousif A.
ElTahir, Kamal E. H.
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (11) : 3416 - 3424
[38] Synthesis, bioassay studies, and molecular docking of novel 5-substituted 1H tetrazoles as cyclooxygenase-2 (COX-2) inhibitors
Baker Jawabrah Al-Hourani
Sai Kiran Sharma
Jatinder Kaur
Frank Wuest
Medicinal Chemistry Research, 2015, 24 : 78 - 85
[39] 4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
Talley, JJ
Bertenshaw, SR
Brown, DL
Carter, JS
Graneto, MJ
Koboldt, CM
Masferrer, JL
Norman, BH
Rogier, DJ
Zweifel, BS
Seibert, K
MEDICINAL RESEARCH REVIEWS, 1999, 19 (03) : 199 - 208
[40] Comparative QSAR analyses of cyclooxygenase-2 (COX-2) inhibitors.
Garg, R
Kurup, A
Mekapati, SB
Hansch, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U436 - U436

← 1 2 3 4 5 →